Naveen Jain
Naveen Jain is Founder & CEO at BlueDot and Viome Life Sciences, and serves as Founder & Executive Chairman at Moon Express. He previously founded InfoSpace and Intelius, with Intelius having been acquired, and is still involved with Moon Express and Viome Life Sciences. His expertise includes personalized nutrition and leadership in molecular biology and space exploration.
Viome Life Sciences acquires Circulate Health for $15M–$50M to combine at-home diagnostics with therapeutic plasma exchange
Viome Life Sciences has acquired Seattle-based Circulate Health in a deal valued between $15 million and $50 million, combining Viome’s at-home diagnostics and personalized supplements with Circulate’s therapeutic plasma exchange service. The merged company, retaining most Circulate staff, aims to expand plasma-exchange clinics, add diagnostics and study biomarkers related to chronic disease and aging.
June 100X Mindset Highlight Reel | Naveen Jain
Naveen Jain, unfiltered 🎤 An hour of the 100x mindset packed into a few minutes 👇 → Making money is a byproduct — not the goal → Why chasing the paycheck is the fastest way to fail → Happiness is transient. Joy is internal. On vision, building for the future, and solving problems that actually make life better. Which line hit hardest? 👇 #naveenjain #100xmindset #entrepreneurship #founders #mindset #startups #innovation #motivation #vision #venturecapital
Making Money Is a Byproduct — Naveen Jain
Why chasing money is the fastest way to fail 💸 Naveen Jain doesn't sugarcoat why most founders don't make it. His take: if you start a company to make money, you rarely succeed. "Making money is simply a byproduct of doing things that improve people's lives." His analogy for it is blunt — focus on the money directly and you'll never get it right. It only shows up when your attention is somewhere else entirely: on the problem. "Entrepreneurs succeed because they focus on solving the problem that actually makes someone's life better." The reframe: money isn't the target. It's…
303. Health at the Molecular Level with Naveen Jain, Founder and CEO of Viome
Today, I'm joined by Naveen Jain, founder of Viome. Analyzing 100M biomarkers, Viome delivers hyper-personalized nutrition and supplement recommendations based on individual molecular biology. In this episode, we discuss the power of personalized medicine. We also cover: • Why DNA testing falls short • Molecular insights into chronic disease • Enabling N-of-1 nutrition and supplement stacks Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider Viome’s Website: https://www.viome.com/ Viome’s Publications: https://www.viome.com/publications - The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout…
Viome Raises $25M, Hires Ex-Amazon Exec Kal Raman as COO to Expand CancerDetect Diagnostic
Viome, a microbiome and health diagnostics startup, raised $25 million and hired former Amazon senior VP Kal Raman as COO to expand its diagnostic division. The company’s CancerDetect test for oral and throat cancer, granted FDA breakthrough device status, exhibits high sensitivity and specificity.
Naveen Jain's Top Business Secrets for Success
What if you could tap into the secrets of a billionaire's success? In this episode, we dive deep into the business advice that has propelled Naveen Jain to the forefront of entrepreneurship. Naveen Jain, the founder of companies like Moon Express and Viome, shares his invaluable insights on entrepreneurship, innovation, money, and the importance of thinking big. Whether you're an aspiring entrepreneur or a seasoned business owner, this interview is packed with actionable advice that can transform your mindset and career. Struggling to scale your business? Learn how to help others AND yourself in our FREE Business Coaching Masterclass. Sign…
Viome Launches Personalized Toothpaste and Gel Leveraging Oral Microbiome Data for $79/Month
Viome, a wellness company, has launched personalized toothpaste and gel products targeting oral health issues using microbiome data from its Oral Health Intelligence test. The MyBiotics system aims to improve dental health by leveraging personalized bacterial insights for a $79 monthly subscription including products and testing.
Viome raises $86.5M Series C and partners with CVS to sell $179 at-home Full Body Intelligence gut test in 200 stores
Seattle-area health tech startup Viome Life Sciences raised an $86.5 million Series C and struck a deal to sell its $179 at-home Full Body Intelligence gut microbiome test in 200 CVS stores and online. Founded by Naveen Jain, Viome analyzes stool, saliva and blood samples and counts investors including Marc Benioff and Khosla Ventures, though some scientists question clinical utility of microbiome kits.
Seattle Startup Proprio Raises $43M Series B After FDA Clears Paradigm Surgical Navigation Platform
Seattle startup Proprio raised $43 million in a Series B round after receiving FDA 510(k) clearance for its Paradigm surgical navigation platform, which provides real-time 3D visualization for clinicians. The system integrates advanced imaging technologies and is preparing for human use this summer.
Viome Life Sciences raises $67M Series C to expand at-home gut, immune and cancer screening tests
Bellevue-based Viome Life Sciences raised over $67 million in Series C funding to expand its at-home health screening test business, bringing total capital raised to more than $150 million. Founder and CEO Naveen Jain said the company plans to grow headcount from about 150 to ~200 and will hire more scientists, researchers, and engineers while keeping lab and supplement manufacturing automated.
Viome Raises $67 Million in Latest Funding Round to Expand Microbiome and Diagnostic Testing
Seattle-based microbiome startup Viome Life Sciences has raised $67 million in a new funding round, bringing its total funding to over $125 million. The company offers stool, saliva, and blood testing kits for personalized health insights and is developing an FDA-designated diagnostic test for oral and throat cancer.
Viome raises $54M to develop saliva-based cancer diagnostics and expand microbiome consumer business
Viome Life Sciences raised $54 million to advance cancer diagnostics and support its consumer microbiome testing and customized supplement business, bringing total funding to over $125 million while targeting $100M revenue and one million customers next year.
Nordstrom to sell Viome’s $199 Health Intelligence microbiome test online and in select stores in 2022
Nordstrom will sell Viome Life Sciences’ Viome Health Intelligence microbiome test for $199 online and in select stores in 2022, with the kit requiring a stool sample. Viome sequences RNA to profile gut microbes and offers AI-driven diet/supplement recommendations plus a $149/month supplement service, though its clinical claims rely on non–peer-reviewed data and have drawn outside skepticism.
Former Tech Leaders Join Biotech: Isilon Founder Sujal Patel, Ex-Microsoft Terry Myerson and Others Lead AI-Driven Life Sciences Startups
Several former software and tech executives are moving into biotech and life sciences startups, bringing AI, machine learning, and tech-style business models to companies that analyze proteins, microbes, and medical records. Their tech backgrounds are reshaping product development and funding approaches at firms such as Nautilus Biotechnology, Truveta, insitro and Viome.
Viome Life Sciences splits into Viome Consumer Services and Viome Health Sciences to separate products from diagnostics and therapeutics
Viome, now Viome Life Sciences, has split into two divisions: Viome Consumer Services for individualized diet and supplement products, and Viome Health Sciences to develop diagnostics, predictive biomarkers and therapeutics for chronic disease and cancer. The Bellevue startup, led by CEO Naveen Jain and backed by investors including Marc Benioff, has over 200,000 customers and expects $100 million in revenue next year.
Viome, backed by Marc Benioff, projects $100M revenue next year and hires ex-GSK exec Dr. Emmanuel Hanon
Viome, a Seattle-area microbiome testing and therapeutics startup backed by Marc Benioff, says it has more than 200,000 customers and expects $100 million in revenue next year while hiring Dr. Emmanuel Hanon as global head of R&D to push into vaccines and drugs.
Organizations
See all 9-
Viome Executive Officer, Director 2017–present, Founder · current
-
Viome Life Sciences Founder & CEO 2016–present · current
-
BlueDot Founder & CEO 2015–present · current
Education
-
XLRI Jamshedpur M.B.A., Personnel Management · 1980–1982
-
Indian Institute of Technology, Roorkee BS Engineering, Industrial Engineering · 1975–1979
